drugset / Trial / NCT02879747

Individualizing Dose of Growth Hormone to Maintain Normal Growth Velocity After Fulfilled Catch up Growth in Children

NCT02879747

Phase 2/3 Completed 99 enrolled Göteborg University Pfizer · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective was to study whether normal growth velocity can be maintained with adapted GH dosage in GH treated prepubertal children who have responded to GH treatment with fulfilled catch up growth (=difference to target height reached, less than - 0.6 SDS).

Timeline

Start
2003-12
Primary completion
2012-03
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Somatropin Protein / enzyme biologic